Answers are grounded in this paper and cite their sources.
Literature review highlights endothelial dysfunction and thromboembolism risk in severe COVID-19 patients, suggesting targeted cardiovascular interventions to prevent fatal complications.
Although the coronavirus disease 2019 (COVID-19) pandemic is still ongoing, the path towards a better future is finally becoming clear as a result of the initiation of COVID-19 vaccination. While pneumonia was initially emphasized as the only complication of COVID-19, it has become clear that fatal complications, such as a thromboembolism, are also likely to occur. In the era of recurring coronavirus infections, it is important to identify the causes and risk factors regarding exacerbations in patients who may develop severe COVID-19. This review describes how to prevent COVID-19 exacerbations in the context of cardiovascular disease, especially exacerbations related to the vascular endothelium.
No takes yet. Share an insight, caveat, or question.
Yokoyama et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: